№ lp_1_2_37090
File format: docx Character count: 23765 File size: 88 KB
Mytolac is a new brand of lanreotide, bioequivalent to Somatuline Autogel, submitted for inclusion under the PBS for the treatment of acromegaly, functional carcinoid tumors, and non-functional GEP-NETs.
Year: 2022
Region / City: Australia
Topic: Medicinal Product Submission
Document Type: Submission for Pharmaceutical Listing
Organization / Institution: Pharmaceutical Benefits Advisory Committee (PBAC)
Author: Not specified
Target Audience: Healthcare professionals, policy makers
Period of Validity: Not specified
Approval Date: 10 August 2022
Date of Changes: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.